|
APPL1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.637700E-04 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.166800E-04 |
| Normal-vs-Stage2 |
3.414000E-02 |
| Normal-vs-Stage3 |
1.869830E-01 |
| Normal-vs-Stage4 |
6.815800E-04 |
| Stage1-vs-Stage2 |
8.459000E-01 |
| Stage1-vs-Stage3 |
5.647600E-01 |
| Stage1-vs-Stage4 |
4.911600E-01 |
| Stage2-vs-Stage3 |
5.911200E-01 |
| Stage2-vs-Stage4 |
5.932600E-01 |
| Stage3-vs-Stage4 |
2.589400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.395900E-04 |
| Normal-vs-AfricanAmerican |
1.255910E-02 |
| Normal-vs-Asian |
8.403700E-03 |
| Caucasian-vs-AfricanAmerican |
8.094600E-01 |
| Caucasian-vs-Asian |
6.712200E-01 |
| AfricanAmerican-vs-Asian |
5.757600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.16869999964042E-07 |
| Normal-vs-Female |
5.289200E-01 |
| Male-vs-Female |
4.38640000000046E-05 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
7.238200E-03 |
| Normal-vs-Extreme_Weight |
2.46959999999907E-05 |
| Normal-vs-Obese |
7.187500E-02 |
| Normal-vs-Extreme_Obese |
9.652400E-02 |
| Normal_Weight-vs-Extreme_Weight |
4.723000E-01 |
| Normal_Weight-vs-Obese |
3.450400E-01 |
| Normal_Weight-vs-Extreme_Obese |
8.237200E-01 |
| Extreme_Weight-vs-Obese |
6.085600E-02 |
| Extreme_Weight-vs-Extreme_Obese |
8.553000E-01 |
| Obese-vs-Extreme_Obese |
4.391200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.277200E-01 |
| Normal-vs-Age(41-60Yrs) |
5.565700E-02 |
| Normal-vs-Age(61-80Yrs) |
3.3506000000072E-06 |
| Normal-vs-Age(81-100Yrs) |
2.480300E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.122000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.004500E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.312990E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.452400E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.480200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.801800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.301590E-03 |
| Normal-VS-Type2 PRCC |
3.57079999999677E-05 |
| Normal-VS-KIRP CIMP |
5.537000E-01 |
| Normal-VS-Unclassified PRCC |
6.472800E-01 |
| Type1 PRCC-VS-Type2 PRCC |
7.624200E-02 |
| Type1 PRCC-VS-KIRP CIMP |
9.241900E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
2.813400E-01 |
| Type2 PRCC-VS-KIRP CIMP |
1.738110E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
4.934000E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
5.325400E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.20960000005166E-06 |
| Normal-vs-N1 |
1.263620E-01 |
| Normal-vs-N2 |
1.715320E-03 |
| N0-vs-N1 |
6.579500E-02 |
| N0-vs-N2 |
6.577200E-01 |
| N1-vs-N2 |
2.471800E-01 |
|
|
